undamentalytics Newsletter
Sign in

Electromed, Inc. key statistics and ratios

In fiscal 2026, Electromed, Inc. had return on equity of 23.3% and a net margin of 15.3%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Jun 20112012Jun 20122013Jun 20132014Jun 20142015Jun 20152016Jun 20162017Jun 20172018Jun 20182019Jun 20192020Jun 20202021Jun 20212022Jun 20222023Jun 20232024Jun 20242025Jun 20252026Jun 2026
Net margin5.6%1.0%−8.8%−8.3%5.6%9.6%8.6%6.5%6.3%12.8%6.6%5.5%6.6%9.4%11.8%15.3%
Return on equity7.2%1.3%−9.2%−9.7%8.2%14.6%12.3%8.6%8.2%14.9%7.5%6.9%8.8%12.5%17.2%23.3%
Return on assets5.1%0.9%−6.9%−7.7%6.6%11.7%10.2%7.3%7.0%13.3%6.7%5.9%7.3%10.5%14.2%18.8%
Effective tax rate37.1%57.4%——10.8%27.3%36.7%33.0%32.2%20.6%25.4%23.1%22.5%26.8%26.7%21.3%
R&D as % of revenue5.4%4.7%4.0%3.0%1.6%1.7%2.3%0.9%1.9%3.2%4.8%3.3%1.9%1.2%1.6%1.8%
SG&A as % of revenue57.2%64.6%77.3%70.4%61.7%62.6%63.4%66.4%65.3%61.4%62.8%65.1%65.7%63.0%61.4%57.9%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

2 of 2 checks passed · June 30, 2026
What it owns · $66m
Short-term assets $57mLonger-term assets $9m
What it owes, and who funded it · $66m
Short-term liabilities $12mLonger-term liabilities $0mShareholders' equity $54m
  • Short-term assets cover short-term liabilities $57m of assets due within a year against $12m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $57m short-term assets against $66,000 of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Electromed, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

69 /100

Moderate moat

How hard Electromed's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 10 / 20

    Cash operating profit has been a median 8.3% of total assets over 10 years.

  • Pricing power 20 / 20

    Gross margin has been a median 76.6%, moving by 1.2 percentage points (standard deviation) across 10 years.

  • Durability 12 / 20

    Operating margin has been a median 10.8%; its worst year was 7.1%.

  • Cash conversion 12 / 20

    Free cash flow was positive in 8 of 10 years, at a median 7.0% of revenue.

  • Discipline 16 / 20

    The diluted share count fell 2.5% over five years; stock-based pay has been a median 2.9% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: ELMD vs RCELELMD vs PDEXELMD vs TELA

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Electromed, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Electromed, Inc.